Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2001, p. 2738-2741, Vol. 39, No. 7
Aventis, F-93235 Romainville,
France,1 and Mycology Reference
Laboratory, Center for Medical Mycology, University Hospitals of
Cleveland,3 and Department of Dermatology, Case
Western Reserve University,2 Cleveland, Ohio
44106-5028
Received 1 September 2000/Returned for modification 9 February
2001/Accepted 19 April 2001
The susceptibility of Aspergillus fumigatus to
mulundocandin, an echinocandin-like compound, and other antifungal
agents was assessed by the National Committee for Clinical Laboratory
Standards (NCCLS) M38-P method, a
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based colorimetric assay, and determination of morphologic alterations by microscopy. In contrast to the NCCLS M38-P
method, which does not predict the activity in vivo, the XTT-based
assay showed that A. fumigatus is susceptible to
mulundocandin. Thus, the XTT-based assay might be useful for
determination of the susceptibilities of molds to echinocandins.
Further evaluation is warranted.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.7.2738-2741.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Utility of
2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenyl-Amino)Carbonyl]-2H-Tetrazolium
Hydroxide (XTT) and Minimum Effective Concentration Assays in the
Determination of Antifungal Susceptibility of Aspergillus
fumigatus to the Lipopeptide Class of Compounds
*
Corresponding author. Mailing address: Mycology
Reference Laboratory, Center for Medical Mycology, University Hospitals
of Cleveland, 11100 Euclid Ave., LKS 5028, Cleveland, OH 44106-5028. Phone: (216) 844-8580. Fax: (216) 844-1076. E-mail:
mag3{at}po.cwru.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»